000			01920 a2200565 4500
005			20250517030052.0
264		0	_c20160919
008			201609s 0 0 eng d
022			_a1437-7799
024	7		_a10.1007/s10157-015-1115-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aShibata, Kanako
245	0	0	_aRenal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1. _h[electronic resource]
260			_bClinical and experimental nephrology _cDec 2015
300			_a1107-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBody Mass Index
650	0	4	_aCarboplatin _xadverse effects
650	0	4	_aCreatinine _xblood
650	0	4	_aCross-Sectional Studies
650	0	4	_aCystatin C _xblood
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate
650	0	4	_aHumans
650	0	4	_aInulin _xmetabolism
650	0	4	_aKidney Function Tests _xmethods
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOxonic Acid _xadverse effects
650	0	4	_aPyridines _xadverse effects
650	0	4	_aTegafur _xadverse effects
700	1		_aYasuda, Yoshinari
700	1		_aKobayashi, Ryo
700	1		_aAndo, Yuichi
700	1		_aShimokata, Tomoya
700	1		_aKamiya, Hideki
700	1		_aHayashi, Mutsuharu
700	1		_aMaruyama, Shoichi
700	1		_aMatsuo, Seiichi
700	1		_aNakao, Makoto
700	1		_aTsuchiya, Teruo
700	1		_aTeramachi, Hitomi
773	0		_tClinical and experimental nephrology _gvol. 19 _gno. 6 _gp. 1107-13
856	4	0	_uhttps://doi.org/10.1007/s10157-015-1115-1 _zAvailable from publisher's website
999			_c24824434 _d24824434